Available at: Accessed April 19, 2019
Poster Session I - DIGITAL TRANSFORMATION, AI AND ROBOTICS 07.00 - DIGITAL TRANSFORMATION, AI AND ROBOTICS - 07.01 - TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE P311 - ESOC25-645 EXPLORING STROKE RECURRENCE MECHANISMS WITH PROTEOMICS AND DATA-DRIVEN METHODS INSIGHTS FROM THE CRESCENDO CONSORTIUM Hui Jeong Jung 1,2 , Johanna Ernst 3 , Johannes Teller 3 , Alejandro Fernndez-Vega 4 , Ralf Lichtinghagen 3 , Ramona Schuppner 3 , Hans Worthmann 3 , Karin Weissenborn 3 , Joan Montaner 4 , Mira Katan 2 , Catherine Jutzeler 1 , Gerrit M
Effects of basic fibroblast growth factor on bone allografts
[3] No equivalent human pharmacokinetic dataset appears in the indexed literature
[2] Pharmacokinetic unknowns We lack good human pharmacokinetic data for injected GHK-Cu: how much intact complex survives in circulation, how much copper is handed off to plasma proteins, how much (if any) reaches the skin as functional complex, and what a safe cumulative copper exposure would be
Well cut through the jargon and get you straight to the good stuff: feeling stronger, sharper, and ready for anything
